EDGEWISE THERAPEUTICS INC (EWTX) Stock News

USA - NASDAQ:EWTX - US28036F1057 - Common Stock

22.88 USD

+0.63 (+2.83%)

Last: 11/21/2025, 12:03:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

EWTX Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Edgewise Therapeutics

Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors

9 days ago - By: Edgewise Therapeutics

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

11 days ago - By: Edgewise Therapeutics

Edgewise Therapeutics Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers

18 days ago - By: Edgewise Therapeutics

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

2 months ago - By: Edgewise Therapeutics

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

2 months ago - By: Edgewise Therapeutics

Edgewise Therapeutics to Present on Sevasemten for Becker and Duchenne Muscular Dystrophies at the 30th International Annual Congress of the World Muscle Society

3 months ago - By: Edgewise Therapeutics

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

3 months ago - By: Zacks Investment Research

Wall Street Analysts Believe Edgewise Therapeutics (EWTX) Could Rally 172.96%: Here's is How to Trade

3 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

3 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

3 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

4 months ago - By: Edgewise Therapeutics

Edgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights

4 months ago - By: Edgewise Therapeutics

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

4 months ago - By: Yahoo Finance - Mentions: PTON UBS STX PNC ...

Peloton upgraded, Booking downgraded: Wall Street's top analyst calls

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

4 months ago - By: The Schall Law Firm

EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

5 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

5 months ago - By: Yahoo Finance

Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy Treatment

5 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

5 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

5 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

5 months ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

5 months ago - By: Benzinga - Mentions: SBUX CRCL AYTU SAIL

This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

5 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

5 months ago - By: Yahoo Finance

Edgewise Therapeutics price target lowered to $35 from $40 at Wedbush

5 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

5 months ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX